Sargent Bickham Lagudis LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 135 filers reported holding TRANSMEDICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Sargent Bickham Lagudis LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q2 2022$138,000
+16.0%
4,4030.0%0.01%
+33.3%
Q1 2022$119,000
+41.7%
4,4030.0%0.01%
+50.0%
Q4 2021$84,000
-42.5%
4,4030.0%0.01%
-50.0%
Q3 2021$146,0000.0%4,4030.0%0.01%0.0%
Q2 2021$146,000
-20.2%
4,4030.0%0.01%
-25.0%
Q1 2021$183,0000.0%4,4030.0%0.02%
+100.0%
Q4 2020$183,0004,4030.01%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q2 2022
NameSharesValueWeighting ↓
Divisadero Street Capital Management, LP 325,000$27,293,5007.89%
Ophir Asset Management Pty Ltd 418,366$35,134,3777.32%
Sandhill Capital Partners LLC 812,844$68,262,6676.22%
Kent Lake Capital LLC 119,129$10,004,4534.60%
Eagle Health Investments LP 232,032$19,486,0473.64%
NEXT CENTURY GROWTH INVESTORS LLC 442,942$37,198,2693.58%
Bullseye Asset Management LLC 83,012$6,9713.50%
First Light Asset Management, LLC 377,464$31,699,4272.48%
Nicholas Investment Partners, LP 367,631$30,873,6512.11%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 671,716$56,410,7102.09%
View complete list of TRANSMEDICS GROUP INC shareholders